AS0011 (235074): A multicenter, phase 3, randomized, double-blind, placebo-controlled, active reference arm study to evaluate the efficacy and safety of bimekizumab in the subjects with active ankylosing spondylitis (AS), a subtype of axial spondyloarthritis (axSpA) with radiographic evidence of disease